Literature DB >> 23813996

Altered mental status and fever.

Tokunbo Ajayi1, Ashmeet Bhatia, Barbara Lambl, Sarah Altamimi.   

Abstract

West Nile virus (WNV) is still the most common cause of neuroinvasive arboviral disease in the USA with a case death of 10-30%. We are reporting a case of a 61-year-old woman with a history of Crohn's disease, fibromyalgia treated with chronic steroid therapy that presented with a day history of fever, confusion and lethargy. She had a lumbar puncture which was notable for lymphocytosis and was positive for WNV. She initially was treated with broad-spectrum antibiotics, which were subsequently discontinued when the diagnosis of WNV neuroinvasive disease (WNND) was made. A high index of suspicion is needed to diagnose WNND, and this should be suspected in elderly immunocompromised patient presenting with altered mental status and lumbar puncture suggestive of aseptic meningitis. Recent study has showed that there is genetic variation in the interferon response pathway which is associated with both risk for symptomatic WNV infection and disease progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23813996      PMCID: PMC3703047          DOI: 10.1136/bcr-2013-009238

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Surveillance of above- and below-ground mosquito breeding habitats in a rural midwestern community: baseline data for larvicidal control measures against West Nile Virus vectors.

Authors:  Tamara A Kronenwetter-Koepel; Jennifer K Meece; Christopher A Miller; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-02

2.  West Nile virus disease and other arboviral diseases--United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-05       Impact factor: 17.586

Review 3.  West Nile virus: the complex biology of an emerging pathogen.

Authors:  Sebastian Ulbert
Journal:  Intervirology       Date:  2011-05-16       Impact factor: 1.763

4.  Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011.

Authors:  K Danis; A Papa; E Papanikolaou; G Dougas; I Terzaki; A Baka; G Vrioni; V Kapsimali; A Tsakris; A Kansouzidou; S Tsiodras; N Vakalis; S Bonovas; J Kremastinou
Journal:  Euro Surveill       Date:  2011-08-25

Review 5.  Manifestations of West Nile neuroinvasive disease.

Authors:  James J Sejvar; Anthony A Marfin
Journal:  Rev Med Virol       Date:  2006 Jul-Aug       Impact factor: 6.989

6.  West nile virus neuroinvasive disease.

Authors:  Roberta L Debiasi
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

7.  Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel.

Authors:  C Klein; I Kimiagar; L Pollak; R Gandelman-Marton; A Itzhaki; R Milo; J M Rabey
Journal:  J Neurol Sci       Date:  2002-08-15       Impact factor: 3.181

8.  Host genetic risk factors for West Nile virus infection and disease progression.

Authors:  Abigail W Bigham; Kati J Buckingham; Sofia Husain; Mary J Emond; Kathryn M Bofferding; Heidi Gildersleeve; Ann Rutherford; Natalia M Astakhova; Andrey A Perelygin; Michael P Busch; Kristy O Murray; James J Sejvar; Sharone Green; John Kriesel; Margo A Brinton; Michael Bamshad
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

9.  Behavioral risks for West Nile virus disease, northern Colorado, 2003.

Authors:  Indira B Gujral; Emily C Zielinski-Gutierrez; Adrienne LeBailly; Roger Nasci
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

  9 in total
  1 in total

1.  West Nile Virus Encephalitis in a Patient with Neuroendocrine Carcinoma.

Authors:  Romina Deldar; Derek Thomas; Anna Maria Storniolo
Journal:  Case Rep Oncol Med       Date:  2016-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.